Madrigal Pharmaceuticals IncMDGL

MDGL current price
$304.50+28.41%

Capital at risk.

1W
-4.98%
1M
-2.21%
3M
+30.47%
6M
+10.04%
1Y
+28.41%
MAX
+219.85%
About Madrigal Pharmaceuticals Inc
Ticker
info
MDGL
Trading on
info
NASDAQ
ISIN
info
US5588681057
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
William J. Sibold
Headquarters
info
Four Tower Bridge, West Conshohocken, PA, United States, 19428
Employees
info
376
Website
info
madrigalpharma.com
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.
Metrics
BasicAdvanced
Market cap
info
$6.69B
P/E ratio
info
-
EPS
info
-$25.04
Dividend Yield
info
0.00%
Beta
info
-0.47
Forward P/E ratio
info
0
EBIDTA
info
$-547M
Ex dividend date
info
-
Price & volume
Market cap
info
$6.69B
Average daily volume
info
0.4M
90-day return
info
30.47%
30-day return
info
-2.21%
7-day return
info
-4.98%
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
0
Trailing P/E
info
0
Price to sales
info
87.04
Price to book
info
8.49
Earnings
EPS
info
-$25.04
EPS estimate (current quarter)
info
-$6.93
EPS estimate (next quarter)
info
-$6.08
EBITDA
info
$-547M
Revenues (TTM)
info
$76.8M
Revenues per share (TTM)
info
$3.71
Technicals
Beta
info
-0.47
52-week High
info
$368.29
52-week Low
info
$168.25
50-day moving average
info
$276.05
200-day moving average
info
$255.12
Short ratio
info
6.8
Short %
info
28.17%
Management effectiveness
ROE (TTM)
info
129.76%
ROA (TTM)
info
52.25%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
187.06%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
21.8M
Float
info
10.7M
Insiders %
info
8.56%
Institutions %
info
105.58%
Analyst Insights & forecasts
info

78% Buy

17% Hold

5% Sell

Based on information from 17 analysts.

Average price target

info
$373.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$5.68
-$5.28
7.58%
Q4 • 23Beat
-$7.38
-$6.28
17.52%
Q1 • 24Beat
-$7.10
-$7.53
5.71%
Q2 • 24Beat
-$4.92
-$6.91
28.80%
Q3 • 24Beat
-
-
-
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$14.6M
$-152M
1,038.20%
Q2 • 24
$62.2M
$-107M
172.04%
Q3 • 24
324.75%
29.62%
83.43%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$1.1B
$243M
22.07%
Q2 • 24
$1.07B
$296M
27.59%
Q3 • 24
2.41%
22.02%
25.04%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-135M
$-122M
$134M
$-140M
Q2 • 24
$-67M
$-202M
$7.5M
$-67.8M
Q3 • 24
50.36%
65.76%
94.44%
51.62%
QoQ growth
QuarterlyAnnual
Sentiment analysis

-1.5

Greed

+1.5

0.75

Last 30 days

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Madrigal Pharmaceuticals Inc share?
Collapse

Madrigal Pharmaceuticals Inc shares are currently traded for $304.50 per share.

How many shares does Madrigal Pharmaceuticals Inc have?
Collapse

Madrigal Pharmaceuticals Inc currently has 21.8M shares.

Does Madrigal Pharmaceuticals Inc pay dividends?
Collapse

No, Madrigal Pharmaceuticals Inc doesn't pay dividends.

What is Madrigal Pharmaceuticals Inc 52 week high?
Collapse

Madrigal Pharmaceuticals Inc 52 week high is $368.29.

What is Madrigal Pharmaceuticals Inc 52 week low?
Collapse

Madrigal Pharmaceuticals Inc 52 week low is $168.25.

What is the 200-day moving average of Madrigal Pharmaceuticals Inc?
Collapse

Madrigal Pharmaceuticals Inc 200-day moving average is $255.12.

Who is Madrigal Pharmaceuticals Inc CEO?
Collapse

The CEO of Madrigal Pharmaceuticals Inc is William J. Sibold.

How many employees Madrigal Pharmaceuticals Inc has?
Collapse

Madrigal Pharmaceuticals Inc has 376 employees.

What is the market cap of Madrigal Pharmaceuticals Inc?
Collapse

The market cap of Madrigal Pharmaceuticals Inc is $6.69B.

What is the P/E of Madrigal Pharmaceuticals Inc?
Collapse

The current P/E of Madrigal Pharmaceuticals Inc is null.

What is the EPS of Madrigal Pharmaceuticals Inc?
Collapse

The EPS of Madrigal Pharmaceuticals Inc is -$25.04.

What is the PEG Ratio of Madrigal Pharmaceuticals Inc?
Collapse

The PEG Ration of Madrigal Pharmaceuticals Inc is 0.

What do analysts say about Madrigal Pharmaceuticals Inc?
Collapse

According to the analysts Madrigal Pharmaceuticals Inc is considered a buy.